arrow
N

Nathan I. Cherny

Shaare Zedek Medical Center
H指数:57
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Reporting health-related quality of life in randomised clinical trials evaluating adjuvant systemic therapy: recommendations of Common-Sense Oncology and the European Organisation for Research and Treatment of Cancer

报告辅助全身治疗随机临床试验中的健康相关生活质量:常识肿瘤学和欧洲癌症研究与治疗组织的建议

2026-09-290
PRE
Asia-Pacific analysis of ESMO study on availability, out-of-pocket costs (OPC) and accessibility of antineoplastic medicines

亚太地区对ESMO研究(关于抗肿瘤药物的可及性、自付费用(OPC)和可及性)的分析

2026-08-010
OAAI
Assessing Overall Survival Benefits in Advanced Cancers: The Role of External Comparator Cohort Studies with Real-World Data

评估晚期癌症总生存获益:外部对照队列研究结合真实世界数据的作用

2026-02-110
OAAI
Importance of responder criteria for reporting health-related quality-of-life data in clinical trials for advanced cancer: recommendations of Common Sense Oncology and the European Organisation for Research and Treatment of Cancer

在晚期癌症临床试验中报告与健康相关的生活质量数据时,应答者标准的重要性:常识肿瘤学与欧洲癌症研究与治疗组织的建议

2025-09-010
PRE
ESMO-Magnitude of Clinical Benefit Scale version 2.0 (ESMO-MCBS v2.0)

ESMO临床获益程度量表2.0版(ESMO-MCBS v2.0)

2025-05-220
PRE
Guidance for discussants of randomized cancer trials at major meetings

重大会议中随机化癌症试验讨论员的指导原则

2025-05-010
PRE
Revised European Association for Palliative Care (EAPC) recommended framework on palliative sedation: An international Delphi study
2024-01-3120
OAAI
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) credit

符合欧洲医学肿瘤学会-临床受益规模 (esmo-mcbs) 信用的生活质量数据的方法和报告标准

2023-04-0119
OA